The Pathophysiologic Basis for Antiparkinsonism Therapy is:

6
1240
pharmacy

The pathophysiologic basis for antiparkinsonism therapy is:

a) A selective loss of dopaminergic neurons

b) The loss of some cholinergic neurons

c) The loss of the GABAergic cells

d) The loss of glutamatergic neurons

6 COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here